Dow Up 0.64% Nasdaq Up 0.68%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.15 Up 0.03(0.96%) 3:53PM EDT
Prev Close:3.12
Open:3.25
Bid:3.07 x 1000
Ask:3.21 x 3000
1y Target Est:9.50
Beta:2.22
Next Earnings Date:N/A
Day's Range:3.13 - 3.30
52wk Range:2.88 - 5.50
Volume:45,706
Avg Vol (3m):89,769
Market Cap:71.43M
P/E (ttm):N/A
EPS (ttm):-0.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCUp 0.96%71.43M
AZNUp 1.23%93.66B
JNJUp 1.09%302.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):52.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback